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The nonstructural protein NS2-3 of pestiviruses undergoes tightly regulated processing. For bovine viral diarrhea virus it was shown that
uncleaved NS2-3 is required for infectious particle formation while cleaved NS3 is essential for genome replication. To further investigate the
functions of NS2-3 and NS4A in the pestivirus life cycle, we established T7 RNA polymerase-dependent trans-complementation for p7-NS2-3-
4A of classical swine fever virus (CSFV). Expression of NS2-3 and NS4A in trans restored the production of infectious particles from genomes
lacking NS2-3 expression. Co-expression of cleaved NS4A was essential. None of the enzymatic activities harbored by NS2-3 were required for
infectious particle formation. Importantly, expression of uncleavable NS2-3 together with NS4A rescued infectious particles from a genome
lacking NS2, demonstrating that cleaved NS2 per se has no additional essential function. These data indicate that NS2-3 and NS3, each in
association with NS4A, have independent functions in the CSFV life cycle.
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Viruses possess a limited number of genes to accomplish the
essential steps of their life cycle and the accessory functions in
virus–host interaction. Consequently, the same coding sequence
or gene product often exerts more than one function. Within the
Flaviviridae family, the genus pestivirus comprises classical
swine fever virus (CSFV), bovine viral diarrhea virus (BVDV)⁎ Corresponding author. Fax: +41 31 848 9222.
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doi:10.1016/j.virol.2007.03.056and border disease virus (BDV). These are small enveloped
viruses with a positive-sense RNA genome of approximately
12.3 kb that consists of a 5′ and a 3′ nontranslated region (NTR)
flanking a large open reading frame (ORF) encoding a
polyprotein of approximately 3400 amino acids. The poly-
protein is co- and post-translationally processed into the 12
mature proteins Npro, C, Erns, E1, E2, p7, NS2, NS3, NS4A,
NS4B, NS5A and NS5B and at least two characterized
precursor proteins, E2-p7 and NS2-3 (Agapov et al., 1998;
Elbers et al., 1996; Harada et al., 2000; Lindenbach and Rice,
2001; Meyers and Thiel, 1996). Except the leader protein Npro,
all the mature processing products and the precursor protein
NS2-3 – as shown recently for BVDV – are essential for the
virus life cycle while the proteins NS3 to NS5B are sufficient
for RNA replication (Agapov et al., 2004; Behrens et al., 1998;
Gil et al., 2006; Lai et al., 2000; Lindenbach and Rice, 2001;
Moser et al., 1999; Tratschin et al., 1998). Npro exerts two
known functions, an autoprotease activity for co-translational
cleavage from the nascent polyprotein (Rümenapf et al., 1998;
Stark et al., 1993; Wiskerchen et al., 1991) and an antagonistic
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2007; Gil et al., 2006; Hilton et al., 2006; Horscroft et al.,
2005; La Rocca et al., 2005; Ruggli et al., 2003, 2005). The C
protein and the envelope proteins Erns, E1 and E2 are released
from the polyprotein by cellular signalases and are components
of the virion (Rümenapf et al., 1991, 1993; Thiel et al., 1991).
C is further processed by a signal peptide peptidase (Heimann
et al., 2006). Erns exists also as secreted form and possesses
RNase activity (Hulst et al., 1994; Schneider et al., 1993).
Downstream of E2, the small hydrophobic protein p7, flanked
by signal peptidase cleavage sites, is essential for infectious
virus production but is not associated with virus particles
(Elbers et al., 1996; Harada et al., 2000). In cell extracts, p7 is
partially associated with E2. Separation of the E2 and p7
genes with an internal ribosome entry site (IRES) resulted in a
viable virus, demonstrating that the E2-p7 precursor protein is
not required for virus replication (Harada et al., 2000). NS2 is
an autoprotease that associates with a cellular chaperone
termed Jiv (J-domain protein interacting with viral protein) and
cleaves the NS2-3 protein between NS2 and NS3 (Lackner et
al., 2004, 2006). The NS3 serine protease cleaves at the
downstream cleavage sites (Tautz et al., 1997, 2000; Xu et al.,
1997). In addition to the serine protease function, NS3
possesses helicase and NTPase activities (Warrener and
Collett, 1995; Tamura et al., 1993) that are essential for viral
RNA replication (Grassmann et al., 1999; Gu et al., 2000).
NS4A associates with the N-terminus of NS3 and acts as a
cofactor for the serine protease activity (Xu et al., 1997). A
role in cytopathogenicity was associated with NS4B (Qu et al.,
2001). NS5A is phosphorylated and was shown to be the only
protein of the replication complex that can be complemented in
trans (Grassmann et al., 2001; Reed et al., 1998). BVDV
NS5A was also found to interact with a subunit of the bovine
translation elongation factor 1A, suggesting a role of this
protein in genome replication and translation (Johnson et al.,
2001). NS5B represents the viral RNA-dependent RNA
polymerase (Steffens et al., 1999; Xiao et al., 2003; Zhong
et al., 1998). Cleavage between NS5A and NS5B is slow.
Accordingly, the precursor protein NS5AB can be detected in
cell extracts and is processed in NS5A and NS5B with a half-
life time of less than 60 min (Collett et al., 1991). Whether
NS5AB has a specific function is unknown. For the NS2-3
precursor protein the situation is different in that unprocessed
NS2-3 forms a stable protein within infected cells (Collett et
al., 1991). Agapov and coworkers demonstrated that an
uninterrupted NS2-3 gene cassette within the viral genome
was essential for the production of infectious bovine viral
diarrhea virus (BVDV) (Agapov et al., 2004). Processing of
NS2-3 to NS2 and NS3 was long thought to be absent in the
noncytopathogenic (ncp) biotype of BVDV and to represent a
specific feature of the cytopathogenic (cp) biotype, with the
accumulation of NS3 leading to the cytopathic effect in cell
culture (for review, see Kummerer et al., 2000; Lindenbach
and Rice, 2001; Meyers and Thiel, 1996). Recently however,
Lackner and coworkers demonstrated that NS3 is essential for
pestiviral RNA replication and cannot be functionally replaced
by the uncleaved NS2-3 precursor (Lackner et al., 2004). TheNS2-mediated cleavage at the NS2-3 site is essential for the
pestivirus life cycle and is temporally modulated by a 1:1
stoichiometric association of NS2 with the cellular cofactor Jiv
(Lackner et al., 2005, 2006). Consumption of the intracellular
Jiv pool that remains tightly associated with NS2, and the
restriction of NS2 to cis-cleavage limits the NS2 activity to
early times after infection, resulting in the virtual absence of
NS2-3 cleavage at later times post-infection and, consequently,
in the reduction of viral RNA replication, which is crucial for
the virus to persist (Lackner et al., 2004, 2005). The limitation
of the specificity of NS2 to cis-cleavage is mediated by the C-
terminal 4 amino acids of NS2 that interfere with trans-
cleavage activity (Lackner et al., 2006). Whether NS2, either
alone or associated with NS3, has additional essential
functions in the virus life cycle is unknown, except for the
role of uncleaved NS2-3 in BVDV morphogenesis identified
by Agapov et al. (2004). This latter study was based on trans-
complementation of a BVDV replicon defective in unpro-
cessed NS2-3 protein with a bicistronic replicon expressing an
uninterrupted p7-NS2-3-4A cassette and mutations thereof.
While the p7 protein was not required in cis on the com-
plementing replicon, expression of NS4A in cis with NS2-3
was essential for optimal rescue of infectious virions in trans
from an NS2-3-defective replicon. These experiments also
suggested that apart from its role in cleaving NS2-3 from
NS4A, the protease activity of NS3 was not an absolute
requirement for infectious virion production (Agapov et al.,
2004). However failure of separate expression of NS2-3 and
NS4A in trans in a replicon-independent context hampered
detailed conclusions on the cis requirements of NS4A in
association with NS2-3 for trans-complementation. Further-
more, the minimal polyprotein region and the catalytic
activities of NS2-3 required for infectious particle formation
have not yet been defined.
For CSFV, NS2-3 processing is observed at all stages of
infection. As opposed to ncp BVDV, NS2-3 and its cleavage
products are present at variable ratios – with usually more
NS2-3 than NS2 and NS3 – in extracts of cells infected with
CSFV that usually is ncp, except for END− strains under
specific cell culture conditions (Aoki et al., 2004). In the
present study, we demonstrate that in analogy to BVDV, CSFV
also requires uncleaved NS2-3 and NS4A for infectious
particle formation. To further dissect the molecular elements
of NS2-3 and NS4A that function in morphogenesis of
infectious virions and to evaluate a potential role of processed
NS2, we established a bacteriophage T7 promoter-driven
trans-complementation system for p7-NS2-3-4A expression.
Our data show that processed NS4A is an indispensable
cofactor of uncleaved NS2-3 in the formation of infectious
particles. Importantly, NS4A can be supplied in trans
separately from NS2-3 without loss of efficiency. We also
demonstrated that NS2, once it is cleaved from the NS2-3
precursor protein by itself has no additional essential function
in the CSFV life cycle. Finally we propose a model in which
the role of NS2-3 and NS4A in infectious virus production is a
function that is independent of the NS3 and NS4A function in
RNA replication.
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CSFV genomes expressing NS2 and NS3 but not the NS2-3
precursor protein are replication-competent but are deficient in
infectious particle formation
In cells infected with CSFV, the protein NS2-3 undergoes
partial cleavage, resulting in the presence of the NS2-3
precursor and of the cleavage products NS2 and NS3 (Fig.
1B, 3rd lane). To study the function of the uncleaved NS2-3Fig. 1. CSFV genomes in which NS2 and NS3 were separated by the murine
ubiquitin gene (Ub) or the EMCV IRES replicate but do not form infectious
virus particles. The genomes A187-1, A187-NS2-Ub-NS3 and A187-NS2-
IRES-NS3 represented schematically in panel Awere transcribed from the full-
length cDNA clones pA187-1, pA187-NS2-Ub-NS3 and pA187-NS2-IRES-
NS3, respectively, and used to transfect SK6 cells by electroporation. (B) After
incubation at 37 °C for 20 h, cell extracts were analyzed by Western blotting
using rabbit anti-NS3 serum. (C) At the same time, transfected cells from a
separate well were fixed and analyzed for E2 and NS3 expression by
immunocytochemistry with mAbs HC/TC26 (anti-E2) and C16 (anti-NS3).
(D) SK6 cells were infected with supernatant of cells that had been transfected
with RNA A187-1, A187-NS2-Ub-NS3 (panels NS2-Ub-NS3) and A187-NS2-
IRES-NS3 (panels NS2-IRES-NS3). After incubation at 37 °C for 15 h the cells
were fixed and analyzed by immunocytochemistry for E2 expression. The mean
titer of infectious virions is indicated below the respective panel in log10
TCID50/ml; n.d.: not detectable.precursor protein, we constructed CSFV genomes from which
expression of NS2-3 is prevented, whereas all the other viral
proteins are expressed, including NS2 and NS3 (Fig. 1A). This
was achieved with two independent approaches. First, a
monocystronic CSFV genome was constructed in which the
murine ubiquitin (Ub) gene was inserted between NS2 and NS3
(A187-NS2-Ub-NS3, Fig. 1A). In cells transfected with this
genome, efficient cleavage between the NS2-Ub fusion protein
and NS3 was observed without any detectable precursor protein
NS2-Ub-NS3 (Fig. 1B, 4th lane). In an alternative approach, the
IRES of encephalomyocarditis virus (EMCV) was inserted
between NS2 and NS3 (A187-NS2-IRES-NS3, Fig. 1A),
leading to the expression of the two proteins NS2 and NS3
from two independent cistrons in absence of the NS2-3
precursor protein (Fig. 1B, 5th lane). Both genomes, A187-
NS2-Ub-NS3 and A187-NS2-IRES-NS3, were cytopathogenic,
as opposed to the parent CSFV genome, and expressed NS3 as
well as E2 in transfected cells (Fig. 1C), indicating that the
mutated viral RNAs were replication-competent. However,
cells could not be infected with the clarified supernatant of cells
that had been transfected with the genomes in which NS2 was
separated from NS3 (Fig. 1D). From this we conclude that
CSFV genomes expressing all the viral proteins but incapable of
producing the uncleaved NS2-3 precursor replicate and are
cytopathogenic, but do not form infectious particles. This is in
agreement with the data obtained for BVDV by Agapov et al.
(2004).
Co-transfection of replicons deficient for NS2-3 expression
with a helper replicon rescues infectious particles
To analyze whether the defect due to the absence of
uncleaved NS2-3 can be complemented in trans from a separate
replicon, we provided NS2-3 with replicon RNA transcribed
from pA187-ΔApa (A187-ΔApa). This latter RNA lacks the
viral genome sequence from nucleotides 660 to 3260 resulting
in the lack of expression of the C-terminal half of Npro and of all
the structural proteins except the C-terminal region of E2. With
this in frame deletion, RNA replication and expression of
the nonstructural proteins spanning from p7 to NS5B are
maintained, as demonstrated by NS3 expression in the absence
of E2 expression (Fig. 2A, left panels). Transfection of a
mixture of A187-ΔApa and either A187-NS2-Ub-NS3 or
A187-NS2-IRES-NS3 RNA resulted in the expression of both
E2 and NS3 (Fig. 2A, middle and right panels). Importantly,
when SK6 cells were treated with the clarified supernatant of
cells that had been transfected with a mixture of A187-ΔApa
and either A187-NS2-Ub-NS3 or A187-NS2-IRES-NS3 RNA,
the cells expressed NS3 and E2 (Fig. 2B, middle and right
panels) as opposed to supernatants from cells that had been
transfected with either A187-NS2-Ub-NS3 or A187-NS2-
IRES-NS3 RNA alone (Fig. 1D, middle and right panels) or
with A187-ΔApa alone (Fig. 2B, left panels). This demon-
strates that the presence of replicating A187-ΔApa RNA had
rescued infectious particles containing the A187-NS2-Ub-NS3
or the A187-NS2-IRES-NS3 RNA. The mean particle titer of
three independent experiments was 2.5 log10 50% tissue culture
Fig. 2. Infectious CSFV particles can be rescued from replicons deficient for
NS2-3 expression with a helper replicon. (A) SK6 cells were transfected with
A187-ΔApa RNA (ΔApa, left panels) or with a mixture of A187-ΔApa and
either A187-NS2-Ub-NS3 or A187-NS2-IRES-NS3 RNA (ΔApa + NS2-Ub-
NS3 or ΔApa + NS2-IRES-NS3, middle and right panels). Twenty hours after
transfection, the cells were immunostained for NS3 and E2 expression with
mAb C16 (anti-NS3) and HC/TC26 (anti-E2), respectively. (B) The clarified
transfection supernatants were transferred onto fresh SK6 cells. After an
incubation period of 15 h at 37 °C the cells were fixed and analyzed by
immunocytochemistry for NS3 and E2 expression. The mean particle titer ±SD
is indicated below the respective panel in log10 TCID50/ml; n.d.: not detectable.
(C) SK6 cells were mock treated (1st lane) or transfected with A187-ΔApa RNA
(2nd lane). After 20-h incubation, cell extracts were immunoprecipitated with
mAb C16 and separated by SDS-PAGE. A crude cell extract of SK6 cells
infected with CSFV vA187-1 was loaded as control (3rd lane). Proteins were
analyzed by Western blotting and immunodetection with rabbit anti-NS3 serum.
The positions of NS2-3 and NS3 are indicated.
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0.2 TCID50/ml with both genomes, A187-NS2-Ub-NS3 and
A187-NS2-IRES-NS3. Interestingly, 99% of the NS2-3 protein
expressed from the A187-ΔApa replicon was processed into
NS2 and NS3 as quantified with the Odyssey imaging system
(Fig. 2C), indicating that even small amounts of uncleaved
NS2-3 were sufficient for the rescue of infectious particles.
Recombination between the two replicons was excluded by
multiple cell culture passages and by RT-PCR using a senseprimer located in E2 and an antisense primer located in NS3
(data not shown). Taken together, these data demonstrate that
the functional defect due to the absence of uncleaved NS2-3 can
be rescued in trans with a separate replicon.
Expression of NS2-3 and NS4A is essential and sufficient for
the rescue of infectious particles from replicons deficient for
NS2-3 expression
Trans-complementation with the A187-ΔApa replicon does
not provide any information whether uncleaved NS2-3 alone is
sufficient for trans-complementation or whether it forms a
complex with other viral proteins recruited in cis or in trans
from the helper replicon. To address these questions we opted
for a replicon-independent expression system for trans-comple-
mentation. Attempts to express NS2-3 using standard cytome-
galovirus (CMV) promoter-driven expression vectors failed.
Therefore, we cloned the NS2-3 region of the CSFV genome
downstream of a bacteriophage T7 promoter and an EMCV
IRES and expressed the protein by providing the T7 polymerase
from a separate expression plasmid. This strategy allows
cytoplasmic transcription, which represents the natural situa-
tion in the CSFV life cycle. As shown in Fig. 3A we
constructed a first set of expression plasmids to determine
which polyprotein combinations were required for trans-
complementation of the NS2-3 defect. All the plasmids
expressed the expected protein (Fig. 3B). Transfection of
SK6 cells with a mixture of the replicon A187-NS2-Ub-NS3,
the plasmid pSC6-T7-Neo and either of the four plasmids
shown in Fig. 3A resulted in strong viral protein expression
when analyzed by anti-NS3 immunocytochemistry (Fig. 3C,
top panels). When the supernatants of these transfected cells
were transferred onto fresh cells, infectious particles with titers
of 4.4 log10 TCID50/ml with a standard deviation (SD) of 0.1
and 0.2 TCID50/ml, respectively, were detected when either p7-
NS2-3-4A or NS2-3-4A was used for complementation. With
p7-NS2-3 and NS2-3 the rescue was dramatically reduced to
only 0.1± 0.1 log10 TCID50/ml (Fig. 3C, bottom panels). Thus,
deletion of NS4A from the expression plasmid dramatically
reduced the ability of NS2-3 to trans-complement the lack of
NS2-3 in A187-NS2-Ub-NS3, although NS4A was expressed
from the replicon.
To determine whether NS4A provided in trans functions as a
cofactor of NS2-3 in the formation of infectious particles, we
co-expressed NS4A protein from the plasmid pSLTM3A-Ub-
NS4A (Fig. 3D). NS4Awas fused to a murine ubiquitin mono-
mer in order to allow expression of NS4Awith the authentic N-
terminus. When NS4Awas expressed separately and combined
with NS2-3 expression, infectious particle formation from
A187-NS2-Ub-NS3 RNA was restored (Fig. 3F, left panels).
This confirms that NS4A is required in association with NS2-3
for infectious particle formation and indicates that NS4A cannot
be recruited from the replicon. In addition, these data indicate
that it is the combination of uncleaved NS2-3 and processed
NS4A rather than the NS2-3-4A polyprotein precursor that is
responsible for infectious particle rescue. A control experiment
in which we provided p7-NS2 and NS3-4A excluded the
Fig. 3. Infectious CSFV particles can be rescued from replicons deficient for NS2-3 expression by T7-driven expression of NS2-3 and NS4A. (A and D) Schematic
representation of the expression constructs employed to assess the role of p7, NS2, NS3 and NS4A in infectious particle formation. The part of the CSFV genome
encoding p7 to NS4Awas cloned downstream of a T7 promoter (arrowhead) and the EMCV IRES (IRES). (B and E) SK6 cells were transfected with the respective
pSLTM3A-derived plasmid encoding the indicated proteins and superinfected with recombinant vaccinia virus vTF7-3. Six hours after infection, cells were lysed and
protein expression was analyzed by SDS-PAGE andWestern blotting (WB) using rabbit anti-NS2 and anti-NS3 sera, and anti-Flag and anti-HAmAbs, as indicated. (C
and F) In order to identify the minimal polyprotein required for trans-complementation (C) and to assess the role of the precursor and of the processed forms of NS2-3
and NS4A in trans-complementation (F), cells were transfected with the RNA genome A187-NS2-Ub-NS3 together with pSC6-T7-Neo and the respective pSLTM3A-
derived plasmids encoding the indicated gene combinations. After 20 h of incubation, the transfection supernatants were collected and clarified by centrifugation and
the respective cell monolayers were analyzed for NS3 expression using rabbit anti-NS3 serum (C and F, top panels). The clarified transfection supernatants were
transferred onto fresh cells. After 15 h of incubation, the cells treated with supernatant were fixed and immunostained for E2 expression using mAb HC/TC26 (C and F,
bottom panels). The mean particle titer ±SD is indicated below the respective panel in log10 TCID50/ml; n.d.: not detectable.
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tion (Fig. 3F, right panels). Proper expression of the latter
proteins was demonstrated by Western blotting (Fig. 3E). In
SDS-PAGE, NS2 expressed from pSLTM3A-p7NS2 migrated
faster than the calculated molecular weight of 52 kDa. Using N-
terminally Flag-tagged and C-terminally HA-tagged NS2, we
demonstrated that this was due to a migration artifact rather than
to a truncation of NS2 (Fig. 3E). Importantly, infectivity was
detected in the supernatants after filtration through 0.2-μm pore
size filters, and was completely neutralized with a polyclonal
serum specific for CSFV (data not shown).
Only minor amino- and carboxy-terminal deletions of the
NS2-3 protein are tolerated for trans-complementation
Having demonstrated that transient expression of NS2-3
together with NS4A rescued infectious particles from genomes
lacking uninterrupted NS2-3, we asked whether the entire NS2-
3 protein was necessary for rescue. To map the minimal domain
required for complementation, a first series of deletions was
performed at the N-terminus of the transiently expressed NS2-3-
4A protein (Figs. 4A and B). Deletion of the 5 N-terminal amino
acids of NS2-3-4A was tolerated for trans-complementation
and release of infectious viral particles from the replicon A187-
NS2-Ub-NS3 whereas removal of 25 amino acids and moreabolished complementation (Fig. 4C). Serial amino acid
truncations were also performed at the C-terminus of NS2-3
(Figs. 4D and E) and the respective proteins co-expressed with
NS4A. Here, a deletion of 20 amino acids at the C-terminus of
NS2-3 was tolerated for infectious particle production from the
defective genome A187-NS2-Ub-NS3 (Fig. 4F). Deletion of 30
or more amino acids, however, suppressed the complementation
capability of NS2-3 (Fig. 4F). Taken together, these data
indicate that, in our trans-complementation system, large dele-
tions are not tolerated, neither at the N- nor at the C-terminus of
the NS2-3 protein.
The protease activity of NS2 is not required for infectious
CSFV particle rescue by NS2-3-4A
Since we had now clearly established that the uncleaved
form of NS2-3 is essential for infectious particle formation, we
postulated that the protease activity of NS2 was not required for
trans-complementation and might even negatively influence the
complementation efficiency. Therefore, we analyzed whether
NS2-3 devoid of the proteolytic activity of NS2 would influence
the efficiency of particle rescue. To this end we mutated the
catalytic residues histidine at position 1447 and cysteine at
position 1512 in the complementing NS2-3-4A polyprotein to
abolish the protease activity of NS2, based on data from
Fig. 4. Analysis of the maximal N- and C-terminal deletions of NS2-3 tolerated for functional trans-complementation. The expression constructs employed to assess the
maximal N-terminal (A) and C-terminal (D) deletions of NS2-3 tolerated for trans-complementation of the genomes defective for NS2-3 expression are represented
schematically. SK6 cells were transfected with the pSLTM3A-derived plasmids encoding NS2-3-4A carrying the indicated N-terminal 5, 25, 45 and 68 amino acid
deletions (Δ5N, Δ25N,Δ45N,Δ68N, respectively) (B), or with plasmids expressing NS2-3 carrying the indicated C-terminal 10, 20, 30 and 50 amino acid deletions
(Δ10C, Δ20C, Δ30C, Δ50C, respectively) (E) and superinfected with recombinant vaccinia virus vTF7-3. The expression plasmids without deletion (NS234A and
NS23) and a plasmid encoding the enhanced green fluorescence protein (mock) were used as controls. Six hours after infection, cells were lysed and protein expression
was analyzed by SDS-PAGE andWestern blotting using rabbit anti-NS3 serum. (C and F) Clarified supernatants of cells that had been transfected with the RNAgenome
A187-NS2-Ub-NS3 andwith pSC6-T7-Neo and the pSLTM3A constructs encodingNS2-3-4Awith the indicatedN-terminal deletions (C) or Ub-NS4A andNS2-3with
the indicated C-terminal deletions (F) were transferred onto fresh SK6 cells. After 15 h of incubation, the cells were fixed and immunostained for E2 expression using
mAb HC/TC26. The mean particle titer ±SD is indicated below the respective panel in log10 TCID50/ml; n.d.: not detectable.
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H1447R and C1512A prevented cleavage of the NS2-3
precursor, even in the presence of the protease cofactor peptide
Jiv90 (Fig. 5A). The cleavage products NS2 and NS3 were
detected exclusively in cells expressing the parent NS2-3-4A
and Jiv90 (Fig. 5A). We then determined the ability of these
mutant NS2-3-4A proteins to restore infectious particle
production in cells transfected with the replicon A187-NS2-
Ub-NS3. With NS2-3-4A carrying the H1447A and C1512A
mutations, we observed infectious particles with titers compar-
able to those obtained with the parent NS2-3-4A (Fig. 5B).
Interestingly, replacement of histidine at the position 1447 with
an arginine residue resulted in a non-functional NS2-3 protein
(Fig. 5B, 2nd panel). Nevertheless, these results demonstrate
that the NS2-3-4A protein is functional in terms of infectious
particle rescue independently of the NS2 protease activity.
Cleaved NS4A together with NS2-3 is essential for the
formation of infectious CSFV particles while the protease
activity of NS3 per se is not required
We have shown above that infectious particles can be
rescued from a replicon lacking uncleaved NS2-3 either with
NS2-3-4A expressed from a single plasmid or with NS2-3 and
NS4A provided from two separate expression plasmids. From
these data it is not clear whether there is a strict requirement for
both NS2-3 and cleaved NS4A, or if uncleaved NS2-3-4A
polyprotein is also functional in infectious particle formation. If
the NS3-mediated cleavage between NS2-3 and NS4A is
essential, one may further ask whether the functional NS3
protease is solely required for the cis-cleavage at the NS3/4A
site or whether the catalytic activity of NS3 has an additional
function in the rescue of infectious particles. To address this, weexpressed NS2-3-4A polyprotein mutants carrying the point
mutations S1752A, H1658A and D1686G described by Tautz et
al. (2000) to inactivate the BVDV NS3 protease activity. In
analogy to BVDV NS3, the S1752A and H1658A mutations
completely abolished processing at the NS3/4A site while the
D1686G substitution did not inactivate this cleavage as
expected (Fig. 5C), since it was shown that this latter mutation
only affects trans-cleavages at the downstream sites (Tautz et
al., 2000). Accordingly, in trans-complementation experiments,
the mutant NS2-3-4A polyproteins deficient in cis-cleavage
between NS3 and NS4A did not rescue infectious particles from
the A187-NS2-Ub-NS3 replicon (Fig. 5D, 1st and 3rd panels)
while the NS234A-D1686G mutant construct was functional
(Fig. 5D, 5th panel). Combination of NS4A expressed from a
separate plasmid with the NS3 protease inactive mutants NS23-
S1752A and NS23-H1658A restored particle rescue (Fig. 5D,
2nd and 4th panels). The latter particle titers were not
significantly different from those obtained with the wild-type
NS2-3 protein and NS4A (Fig. 3F). It must be noted that co-
expression of NS4A and uncleavable NS234A-S1752A did not
rescue infectious particles (data not shown). All together, these
data clearly demonstrate that the release of NS4A and the
combination with uncleaved NS2-3 are absolute requirements
for the formation of infectious CSFV particles while the
protease activity of NS3 per se does not play an additional
essential role in this process.
Mutations of the catalytic domains of the helicase and NTPase
of NS3 do not abolish trans-complementation of NS2-3
It is known for BVDV and other Flaviviridae that NS3
possesses NTPase and RNA helicase activities (Kim et al.,
1995; Tamura et al., 1993; Warrener and Collett, 1995). The
Fig. 5. Analysis of the role of the catalytic domains of NS2-3 in the formation of infectious CSFV particles. SK6 cells were transfected with pSLTM3A-derived plasmids
encoding NS2-3 and NS4A carrying the indicated single amino acid substitutions to abolish the proteolytic activity of NS2 (A) and NS3 (C) and to affect the helicase
andNTPase activity of NS3 (E). Themutations are indicated by the original amino acid, the position of the mutation (based on the amino acid sequence of the Alfort/187
polyprotein) and by the newly introduced amino acid. The proteolytic activity of NS2was assessed in absence (−) and in presence (+) of exogenously expressed cofactor
Jiv90 using plasmid pGST-Jiv90 (A). Protein expression in cell lysates was analyzed 6 h after infection with recombinant vaccinia virus vTF7-3 by SDS-PAGE and
Western blotting using rabbit anti-NS3 and anti-NS2 sera. For the NS3 protease mutants (C), one and two asterisks indicate the positions of NS2-3 and NS2-3-4A,
respectively. Clarified supernatants of cells that had been transfected with the RNA genome A187-NS2-Ub-NS3 and with the plasmids pSC6-T7-Neo and pSLTM3A
encoding NS2-3-4A, respectively NS2-3 and NS4A, with the indicated amino acid substitutions abolishing the NS2 (B) and NS3 protease activities (D) and the NS3
helicase activity (F) or with the parent sequence as control, were transferred onto fresh SK6 cells. After 15 h of incubation, the cells were fixed and immunostained for
E2 expression using mAb HC/TC26. The mean particle titer ±SD is indicated below the respective panel in log10 TCID50/ml; n.d.: not detectable.
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Walker II motif, and is classified in the superfamily 2 of the
RNA helicases (Jankowsky and Jankowsky, 2000). The RNA
helicase activity is essential for viral RNA replication, but its
precise role remains unclear. In the context of the present studies
we addressed the question whether the helicase activity of NS2-
3 is required for infectious CSFV particle production. Plasmids
encoding NS2-3-4A proteins were mutated to inactivate the
helicase activity or both the helicase and the NTPase activities.
Mutations of the motif DExH/D (where x represents any amino
acid, DEYH in CSFV) to LEYH and DEYA were reported to
reduce the helicase activity of BVDV NS3 and to be lethal for
the virus, whereas mutation to DETH had no effect as expected
(Grassmann et al., 1999; Gu et al., 2000). The CSFV NS2-3-4A
proteins harboring the substitutions Y1912T, D1910L and
H1913A resulting in the mutated helicase domains DETH,
LEYH and DEYA, respectively (Fig. 5E), were used to trans-
complement the replicon A187-NS2-Ub-NS3 (Fig. 5F, 1st, 2ndand 3rd panels). With the exception of the D1910L substitution
(Fig. 5F, 2nd panel), the NS2-3-4A helicase mutants rescued
infectious particles (Fig. 5F, 1st and 3rd panels) with titers
indistinguishable from those obtained with the parent NS2-3-
4A. To completely abolish the helicase and NTPase activities of
NS2-3-4A, we mutated the Walker I motif consisting of GKT to
GAT (mutation K1821A) according to data published for BVDV
(Gu et al., 2000). The NS2-3 protein with this latter mutation
remained functional in terms of infectious particle formation
(Fig. 5F, 4th panel). Taken together, these experiments show that
the helicase and NTPase activities of NS2-3 are not required for
functional NS2-3-4A in infectious particle rescue.
The processed form of NS2 per se is dispensable for the virus
life cycle
We and others have now demonstrated that the uncleaved
NS2-3 protein is an absolute requirement for infectious pesti-
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is also clearly established that NS2 is dispensable for pestiviral
RNA replication while NS3 is essential (Behrens et al., 1998;
Lackner et al., 2004; Moser et al., 1999). Therefore, we asked
whether infectious virions could be rescued from replicons
lacking NS2 by co-expression of NS2-3 and NS4A. To this end
we constructed a CSFV genome in which the NS2 gene was
replaced with an EMCV IRES (A187-p7-IRES-NS3, Fig. 6A).
This replicon encodes all the viral proteins except NS2 and the
NS2-3 precursor protein. When SK6 cells were transfected with
A187-p7-IRES-NS3 RNA in presence of NS2-3-4A expression,
infectious particles were rescued and released into the
transfection supernatant (Fig. 6B, 2nd panel). Importantly,
infectious particles were rescued with the same efficiency when
NS2-3-4A carrying inactive NS2 protease was co-expressed
(Fig. 5A and Fig. 6B, 3rd and 4th panels). This demonstrates
that complementation of the NS2-3 defect functions in the
absence of cleaved NS2 protein, since NS2 was not provided
from the replicon to be complemented nor from the expression
plasmid. We conclude from these data that NS2 protein is not
essential for the production of infectious CSFV particles. In
other words, once NS2 is processed from the NS2-3 precursor
protein, it does not exert any additional essential role in the virus
life cycle.
Discussion
The best characterized processes of the pestivirus life cycle
are the viral RNA replication and polyprotein processing events
(for selected reviews and original publications see Harada et al.,
2000; Heimann et al., 2006; Lackner et al., 2004; Lindenbach
and Rice, 2001; Meyers and Thiel, 1996; Tautz et al., 2000).
Recent studies provided insight into the mechanisms involved
in virus entry (Grummer et al., 2004; Krey et al., 2005, 2006;
Maurer et al., 2004; Wang et al., 2004). Little is known on the
pestivirus assembly and infectious particle formation. AnFig. 6. The processed form of NS2 is not required for the virus life cycle. (A)
Schematic representation of the A187-p7-IRES-NS3 genome in which NS2 was
deleted and replaced with the EMCV IRES. (B) Clarified supernatant of SK6
cells that had been transfected with the genome A187-p7-IRES-NS3 alone (left
panel), or together with pSC6-T7-Neo and pSLTM3A plasmids encoding the
indicated proteins was transferred onto fresh SK6 cells. After 15 h of incubation,
the cells were fixed and immunostained for E2 expression using mAb HC/TC26.
The mean particle titer ±SD is indicated below the respective panel in log10
TCID50/ml; n.d.: not detectable.interesting feature of the pestivirus polyprotein processing is
the simultaneous occurrence of the unprocessed NS2-3
precursor and of the cleaved proteins NS2 and NS3, and their
relationship to cytopathogenicity in cell culture (Aoki et al.,
2004; Kummerer et al., 2000; Lackner et al., 2004; Meyers and
Thiel, 1996). Agapov and coworkers recently identified the
essential role of the uncleaved NS2-3 precursor protein in the
formation of infectious BVDV particles. Here we extended
these studies to CSFV with an in depth characterization of the
requirements with regard to the proteins NS2-3 and NS4A in the
process of infectious particle formation. By inserting a ubiquitin
gene or an EMCV IRES between the sequences encoding NS2
and NS3, we established two CSFV genomes that express all
the viral proteins except the uncleaved NS2-3 precursor protein.
In analogy to BVDV (Agapov et al., 2004), such genomes
replicate but do not produce any detectable infectious particles.
For BVDV, the lack of NS2-3 was complemented with a
duplication of NS2-3 on the same genome or in trans with NS2-
3 expressed from a separate cistron on a second BVDV replicon
(Agapov et al., 2004). In the present study, we used a replicon-
independent trans-complementation system to restrict comple-
mentation to the minimal CSFV genome elements required for
infectious particle rescue. In addition, because RNA splice sites
were described in the pestivirus genes (Reimann et al., 2003;
Schmitt et al., 1999; Shiu et al., 1997), we chose a nucleus-
independent expression system, which mimics the CSFV-
mediated gene expression. To this end we cloned the proteins p7
to NS4A into an expression plasmid under the control of a
bacteriophage T7 promoter downstream of an EMCV IRES for
cytoplasmic transcription and for cap-independent translation,
respectively. With this system we demonstrated that proteins
NS2-3 and NS4Awere essential and sufficient for the rescue of
infectious CSFV particles from a genome lacking expression of
uncleaved NS2-3. Importantly, the fact that viral proteins
expressed from an independent system can rescue infectious
particles from the defective RNA genomes excludes the
presence of a packaging signal on the RNA encompassing the
junction between NS2 and NS3. Specific RNA packaging
signals were found for example in nsP1 and nsP2 of
alphaviruses (Frolova et al., 1997; Weiss et al., 1994; White
et al., 1998). Another nonstructural pestivirus protein that was
shown to play a role in virion assembly is NS5B of BVDV,
suggesting that replication and assembly are functionally
coupled (Ansari et al., 2004). An essential role of viral
nonstructural proteins in infectious particle formation has also
been found for Kunjin virus and Venezuelan equine encephalitis
virus (VEE) (Liu et al., 2003; Pijlman et al., 2006; Volkova et
al., 2006). It is important to note that the two latter reports show
that NS3 of Kunjin virus and nsP1 to nsP3 of VEE are required
in cis. This is fundamentally different from the situation with
pestiviruses for which it is now clear that the NS2-3 precursor
can be provided in trans (this study and Agapov et al., 2004).
Interestingly, only little amounts of the NS2-3 protein were
sufficient for trans-complementation. This is suggested by the
fact that the helper replicon A187-ΔApa complemented the
genomes lacking NS2-3 despite low levels of NS2-3 expression
when compared with the amounts of NS3. In addition, T7
Fig. 7. Model for the differential role of the NS3/4A in replication (A) and of
NS2-3/4A in infectious virion morphogenesis (B). The viral structural and
nonstructural proteins are shown schematically. According to Lackner et al.
(2004, 2006), NS2 in association with the Jiv cofactor cleaves the NS2-3
precursor in cis early after infection, which engages NS3 together with NS4A in
the downstream cleavage events and in the formation of the replication complex
(A). Our data demonstrate that a fraction of NS2-3 remains uncleaved and
recruits cleaved NS4A that can be provided in trans but cannot be recruited from
the replication complex. NS2-3 together with NS4A then functions in the
process of infectious particle formation (B) independently of NS3/4A involved
in RNA replication (A).
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ified vaccinia virus did not increase the efficiency of infectious
particle rescue when compared with pSC6-T7-Neo-mediated
expression (data not shown). For hepatitis C virus (HCV),
studies with intergenotypic chimeric genomes showed that the
proteins p7 and NS2 contribute to the efficiency of infectious
particle formation (Yi et al., 2007). It was also shown that
unprocessed NS2-3 of HCV was rapidly degraded via the
proteasome pathway and that this was dependent on NS2
(Welbourn et al., 2005). In our case, T7 promoter-driven
expression of uncleaved NS2-3 was always lower when
compared with NS3 expression, suggesting that the turnover
of the precursor protein is different from the turnover of the
processed form. However, as opposed to HCV we observed
only a slight increase of uncleaved NS2-3 in the presence of
proteasome inhibitor MG132 (data not shown).
Importantly, in trans-complementation experiments NS4A
has to be provided together with the uncleaved NS2-3 from the
same or from a separate expression plasmid although NS4A is
expressed from the replicons A187-NS2-Ub-NS3, A187-NS2-
IRES-NS3 and A187-p7-IRES-NS3 to be complemented. One
explanation for this observation might be that NS4A associates
co-translationally with NS3 and cannot be further recruited by
NS2-3 expressed in trans. This hypothesis is in accordance with
data from HCV showing that NS4A has a stronger affinity for
NS3 than for NS2-3 (Welbourn et al., 2005). From crystal-
lization studies with NS3 and NS4A of HCV (Kim et al., 1996;
Love et al., 1996; Yan et al., 1998) it was clearly established that
the central part of NS4A forms a beta sheet inserted into the N-
terminal β-barrel of the protease domain of NS3. This
interaction allows the correct folding of the NS3 protein and
activates the protease required for cleavage at the NS4A/NS4B,
NS4B/NS5A and NS5A/NS5B sites. Moreover, the hydro-
phobic N-terminal part of NS4A appears to form a trans-
membrane segment required for NS3 targeting and anchoring to
the endoplasmic reticulum membrane (Wolk et al., 2000). Taken
together, these observations on the structure of HCV NS3-4A
show that NS4A is important for the correct conformation,
topology and functionality of NS3 within the infected cell.
Although the crystal structure of the pestivirus NS2-3,
respectively NS3 is not known, data from the present study
and from others (Agapov et al., 2004) suggest a similar cofactor
role of NS4A for the correct function of NS2-3. Another
function of NS4A could be to recruit other viral or cellular
proteins, as for example NS4B and NS5A for which an
interaction with NS4Awas reported for HCV (Lin et al., 1997).
Separate expression of NS4A allowed the analysis of the
effect of sequential deletions from both ends of the NS2-3
protein on trans-complementation. These data showed that
nearly the entire NS2-3 protein was required. The known
enzymatic activities of the NS2-3 protein however were
dispensable for NS2-3 and NS4A to be functional in infectious
particle formation, as shown with single amino acid substitu-
tions at the active sites of the NS2 and NS3 protease and of the
helicase and NTPase. Our data with the NS2 protease mutants
also confirm that the catalytic residues identified for BVDV
(Lackner et al., 2004) are indeed identical in CSFV. It isimportant to note that NS4A acts as a cofactor of NS2-3 in its
cleaved form only. In that sense, the functional NS3 protease is
essential to provide cleaved NS4A but is then not further
required in infectious particle formation per se. This confirms
the data obtained with BVDV (Agapov et al., 2004) and fits into
the concept that NS2-3 associated with NS4A has a function
that is independent from that of NS3/4A in the replication
complex. In the same line, we asked whether NS2 produced
after autoproteolytical processing from the precursor NS2-3
(Lackner et al., 2004) has by itself an essential function in the
pestivirus life cycle. Co-expression of an uncleavable NS2-3
protein in trans rescued infectious particles from the genome
lacking NS2. Although the presence of undetectable amounts of
NS2 could not be completely excluded these results provide a
strong indication that, as opposed to NS3 and NS2-3, the mature
NS2 protein, once it is released from NS2-3, exerts no other
essential function in the CSFV life cycle. Nevertheless, NS2
might exert other functions not required for the viral life cycle.
For HCV, NS2 was shown to inhibit gene expression from
different cellular promoters (Dumoulin et al., 2003; Kaukinen et
al., 2006) as well as to interfere with cell proliferation (Yang et
al., 2006).
Together with previous results obtained by others (Agapov
et al., 2004; Lackner et al., 2004) our data lead to a model in
which NS2-3 and NS4A are engaged in the assembly pathway,
in a process independent from RNA replication where NS3/4A
is involved (Fig. 7). After entry of the virus and release of the
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to a polyprotein that is co- and post-translationally processed
by viral and cellular proteases. NS2 exerts two essential
functions, the autoproteolytical cleavage and the protease-
independent function in infectious particle formation in the
context of uncleaved NS2-3 protein. Once cleaved by NS2, the
NS3 protein interacts with NS4A and with the downstream
nonstructural proteins of the replication complex at the
membrane of the endoplasmic reticulum where negative-
sense RNA templates and progeny viral genomes are produced
(Lackner et al., 2004; Tautz et al., 2000; Xu et al., 1997) (Fig.
7A). For these processes, the protease, helicase and NTPase
activities of NS3 are essential (Grassmann et al., 1999; Gu et
al., 2000). The NS2-mediated cleavage between NS2 and NS3
and its temporal modulation by the cellular cofactor Jiv is a
crucial regulatory process of the pestivirus life cycle (Lackner
et al., 2004, 2005, 2006), acting as a switch between RNA
replication and infectious particle formation. Reduced cleavage
between NS2 and NS3 later during infection provides
uncleaved NS2-3 protein that associates co-translationally
with NS4A and enters the particle assembly process (Fig.
7B). Another consequence of the reduced NS2-3 cleavage is
decreased viral RNA replication because NS2-3 cannot
functionally replace NS3 in the replication complex (Lackner
et al., 2004). The observation that uncleaved NS2-3 recruited
for virion assembly does not require the enzymatic activities of
NS3 essential for RNA replication further supports the
hypothesis that NS2-3 and NS3, each in association with
NS4A have independent functions in the CSFV life cycle.
Future work will focus on the identification of the molecular
mechanisms by which NS2-3 together with NS4A leads to
infectious particle formation.
Materials and methods
Cells and viruses
The swine kidney cell line SK6, kindly provided by M.
Penseart (Faculty of Veterinary Medicine, Ghent, Belgium) was
propagated in Earle's minimal essential medium (EMEM)
supplemented with 7% horse serum. CSFV vA187-1 was
generated from the cDNA clone pA187-1 (Ruggli et al., 1996).
Recombinant vaccinia virus vTF7-3 expressing the T7 RNA
polymerase was obtained from Bernard Moss (Laboratory of
Viral Diseases, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda, MD, U.S.A.)
and propagated in HeLa cells obtained from the American Type
Culture Collection, Manassas, VA, USA.
Plasmid constructs
Plasmid pA187-1 (Ruggli et al., 1996) carrying the full-
length genome of the Alfort/187 strain (GenBank accession no.
X87939) served as a basis for the construction of all mutant
replicon cDNA clones. The nucleotide numbers included in the
present study refer to this strain. All mutant constructs were
generated using standard DNA cloning techniques. Mutagen-esis was performed by PCR with PfuTurbo DNA polymerase
(Stratagene). The mutagenized DNA fragments were all verified
by nucleotide sequencing using the Thermo Sequenase
DYEnamic direct cycle sequencing kit (GE Healthcare) and
the Global IR2 System with e-Seq software (LI-COR). Plasmid
pA187-NS2-Ub-NS3 contains the entire Alfort/187 genome
with the murine Ub gene inserted between the NS2 and NS3
genes. The Ub gene was amplified from a template plasmid
kindly provided by Charles M. Rice (The Rockefeller
University, New York, NY, U.S.A.). For construct pA187-
NS2-IRES-NS3 the NS2 and NS3 genes of the Alfort/187
genome were separated with a modified EMCV IRES. Briefly, a
stop codon was inserted at the end of the NS2 gene, followed by
the EMCV IRES derived from plasmid pCITE-1 (Novagen) and
fused to the NS3 gene with a start codon inserted in the context
of a Kozak consensus. In addition the last two ATG codons
located at the 3′ end of the EMCV IRES were deleted. In
plasmid pA187-p7-IRES-NS3, the NS2 gene was deleted and
replaced with a stop codon immediately downstream of p7
followed by the EMCV IRES and a start codon within a Kozak
consensus sequence upstream of the NS3 gene. For this
construct, the 5′ and 3′ parts of the EMCV IRES of pCITE1
and pCITE2 respectively were fused at the KpnI site. Plasmid
pA187-ΔApa was described previously (Moser et al., 1999).
For bacteriophage T7 promoter-driven protein expression, the
plasmid pSLTM3 was generated by combining the backbone of
pSL1180 (GE Healthcare) with the T7 promoter, the EMCV
IRES, the multiple cloning site and the T7 terminator sequence
of pTM3 (Moss et al., 1990) kindly provided by Bernard Moss
(Laboratory of Viral Diseases, National Institute of Allergy and
Infectious Diseases, National Institute of Health, Bethesda, MD,
U.S.A). Briefly, the BspDI to HpaI fragment of pTM3 was
introduced into the HindIII and EcoRI sites of pSL1180 after
filling-in the 3′ overhangs of both fragments with Klenow DNA
polymerase. The CSFV genome segment encoding p7, NS2,
NS3 and NS4A was derived from pA187-1 and cloned
downstream of the start codon in pSLTM3A, leading to
pSLTM3A-p7NS234A. PCR-meditated mutagenesis was then
used to construct all variants derived from this expression
plasmid. The mutant expression constructs and their features are
described in Table 1. The details of all the plasmid constructions
described can be obtained on request. The plasmid pSC6-T7-
Neo (Radecke et al., 1995) encoding the T7 RNA polymerase
gene under the control of the cytomegalovirus (CMV) promoter
was obtained from Martin A. Billeter (Institute of Molecular
Biology, University of Zürich, Switzerland). Plasmid pGST-
Jiv90 (Lackner et al., 2005) was a kind gift of Norbert Tautz
(Institut für Virologie, Justus-Liebig-Universität Giessen,
Giessen, Germany).
Immunoreagents
The rabbit anti-NS3 and anti-NS2 sera were prepared against
recombinant protein expressed in Escherichia coli and synthetic
peptides, respectively. For the expression of a portion of the
NS3 protein, a DNA fragment coding for amino acids 1879 to
2022 (amino acids 290 to 433 of NS3) of the CSFV ORF was
Table 1
Features of the pSLTM3A-derived expression constructs
Plasmid name Insert a Features
pSLTM3A-p7NS234A 1063–2336 p7, NS2, NS3, NS4A genes
pSLTM3A-p7NS23 1063–2272 p7, NS2, NS3 genes
pSLTM3A-NS234A 1133–2336 NS2, NS3, NS4A genes
pSLTM3A-NS23 1133–2272 NS2, NS3 genes
pSLTM3A-p7NS2 1063–1589 p7, NS2 genes
pSLTM3A-Flag-NS2 1133–1589 FLAG-tag b, NS2 gene
pSLTM3A-Flag-NS2-HA 1133–1589 FLAG-tag, NS2 gene, HA-tag c
pSLTM3A-NS34A 1590–2336 NS3, NS4A genes
pSLTM3A-Ub-NS4A 2273–2336 Murine ubiquitin gene, NS4A gene
pSLTM3A-NS234A-Δ5N 1138–2336 Deletion of 5 aa d at the N-terminus of NS2
pSLTM3A-NS234A-Δ25N 1158–2336 Deletion of 25 aa at the N-terminus of NS2
pSLTM3A-NS234A-Δ45N 1178–2336 Deletion of 45 aa at the N-terminus of NS2
pSLTM3A-NS234A-Δ68N 1201–2336 Deletion of 68 aa at the N-terminus of NS2
pSLTM3A-NS23-Δ10C 1133–2262 Deletion of 10 aa at the C-terminus of NS3
pSLTM3A-NS23-Δ20C 1133–2252 Deletion of 20 aa at the C-terminus of NS3
pSLTM3A-NS23-Δ30C 1133–2242 Deletion of 30 aa at the C-terminus of NS3
pSLTM3A-NS23-Δ50C 1133–2222 Deletion of 50 aa at the C-terminus of NS3
pSLTM3A-NS234A-H1447A 1133–2336 Inactive NS2 protease
pSLTM3A-NS234A-H1447R 1133–2336 Inactive NS2 protease
pSLTM3A-NS234A-C1512A 1133–2336 Inactive NS2 protease
pSLTM3A-NS234A-S1752A 1133–2336 Inactive NS3 protease in cis and in trans
pSLTM3A-NS23-S1752A 1133–2272 Inactive NS3 protease in cis and in trans
pSLTM3A-NS234A-H1658A 1133–2336 Inactive NS3 protease in cis and in trans
pSLTM3A-NS23-H1658A 1133–2272 Inactive NS3 protease in cis and in trans
pSLTM3A-NS234A-D1686G 1133–2336 Inactive NS3 protease in trans
pSLTM3A-NS23-D1686G 1133–2272 Inactive NS3 protease in trans
pSLTM3A-NS234A-Y1912T 1133–2336 DEYH to DETH, reduced helicase activity
pSLTM3A-NS234A-D1910L 1133–2336 DEYH to LEYH, reduced helicase activity
pSLTM3A-NS234A-H1913A 1133–2336 DEYH to DEYA, reduced helicase activity
pSLTM3A-NS234A-K1821A 1133–2336 GKT to GAT, inactive NTPase and helicase
a Amino acid sequence encoded by the pSLTM3A-derived constructs, numbered according to the CSFVAlfort/187 polyprotein.
b FLAG-tag: amino acid sequence DYKDDDDK.
c HA-tag: amino acid sequence YPYDVPDYA.
d aa: Amino acids.
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introduced into the bacterial protein expression vector pET-15b
(Novagen). The resulting plasmid was used to transform E. coli
BL21(DE3) cells (Stratagene, La Jolla CA, USA) for protein
expression. The fusion protein containing six histidine residues
at its amino terminus was expressed by induction of a log phase
culture with 1 mM isopropyl b-D-thiogalactopyranoside (IPTG)
at 30 °C for 3 h. For purification of the protein by nickel chelate
affinity chromatography, cells were lysed in denaturing buffer
(6 M guanidine hydrochloride, 100 mM NaH2PO4, 10 mM
Tris–HCl, pH 8.0). The supernatant obtained after low speed
centrifugation of the lysate was loaded on a 5 ml Ni2-NTA-
agarose column (QIAGEN). The column was washed with 8 M
Urea, 100 mMNaH2PO4, 10 mM Tris–HCl, pH 8.0 and 6.3 and
the protein eluted at pH 4. The eluted protein was dialysed
against phosphate-buffered saline (PBS). As an immunogen to
obtain serum directed against the carboxy-terminal part of NS2,
a custom-synthesized 17-mer peptide coupled to ovalbumin
(Neosystem, S.A. Strasbourg, France) and corresponding to
amino acids 1520 to 1536 (amino acids 390 to 406 of NS2) of
the CSFV ORF was used. The antisera were produced in New
Zealand white rabbits as described before (Ruggli et al., 2005).
The E2-specific monoclonal antibody (mAb) HC/TC26 (Grei-ser-Wilke et al., 1990) and the NS3-specific mAb C16 (Greiser-
Wilke et al., 1992) were kindly provided by I. Greiser-Wilke,
Hannover Veterinary School, Hannover, Germany. The anti-
FLAG M2 and the anti-HA mAbs were purchased from Sigma.
Alexa Fluor 680 goat anti-rabbit and anti-mouse IgG were from
Molecular Probes Inc. and the biotinylated rabbit anti-mouse
IgG was from DAKO A/S, Glostrup, Denmark.
In vitro transcription and electroporation
Plasmid constructs derived from cDNA clone pA187-1 were
linearized at the transcription run-off site with SrfI and in vitro
transcribed using the MEGAscript T7 Kit (Ambion). After
DNaseI treatment and purification with S-400 HR Sephadex
columns (GE Healthcare), RNA was quantified using a
spectrophotometer. Electroporations were performed using
4×106 cells, 2.5 μg of each replicon RNA, 4 μg pSC6-T7-
Neo and 8 μg pSLTM3A-derived expression plasmid. Cell
supernatant was collected after 20 h, cleared by centrifugation at
15,000×g for 20 min at 4 °C prior to titration on SK6 cells. For
the overexpression of Jiv90, 8 μg of plasmid pGST-Jiv90 was
co-transfected together with the pSLTM3A expression plasmid
encoding the protein of interest.
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Cells were dried for 30 min at 37 °C and fixed at 80 °C for
2 h. PBS supplemented with 0.1% Tween 20 was used as
dilution and wash buffers. Each antibody incubation step was
carried out for 30 min at 37 °C. Biotinylated rabbit anti-mouse
IgG was used as secondary reagent, followed by incubation
with streptavidin coupled to horseradish peroxidase and with
chromogen solution (4 mg/ml 3-amino-9-ethyl-carbazol in N,N-
dimethylformamide) as previously described (Mittelholzer et
al., 1997). Specific staining was visualized by light microscopy.
Infection with vTF7-3
Cells (4×106) were electroporated with 4 μg pSLTM3A-
derived expression plasmids encoding the different CSFV genes
under T7 promoter. Two hours after transfection, adherent cells
were infected with vTF7-3 at a multiplicity of infection of 10
plaque-forming units per cell. After 6 h cells were lysed and
proteins were separated by sodium dodecyl sulfate polyacryla-
mide gel electrophoresis (SDS-PAGE) and analyzed by Western
blotting as described below.
Immunoprecipitation
Transfected cells were trypsinized, washed with PBS and
lysed in a hypotonic buffer (20 mM Tris–HCl pH 7.4, 75 mM
NaCl, 2.5 mM MgCl2, 0.1% NP-40, 1 mM DTT) for 20 min on
ice. Lysates were cleared by centrifugation at 15,000×g for
15 min at 4 °C prior to the addition of the anti-NS3mAb C16 at a
dilution of 1/100. The protein antibody mixture was incubated
for 1 h at 4 °C on a turningwheel. Protein G sepharose beads (GE
Healthcare) were added and incubation was carried on for 1 h at
4 °C. Beads were washed with lysis buffer containing 200 mM
NaCl, and the proteins were eluted from the beads with 30 ml
SDS loading buffer. Eluted proteins were separated by SDS-
PAGE and detected by Western blotting as described below.
Western blotting
Proteins were analyzed by Western blotting essentially as
previously described (Ruggli et al., 2005). Briefly, cells were
lysed in a hypotonic buffer containing 20 mM morpholinepro-
panesulfonic acid, 10 mM NaCl, 1.5 mM MgCl2, 1% Triton X-
100, pH 6.5, and 1 ml/106 cells protease inhibitor cocktail
(Sigma). After clarification by centrifugation at 15,000×g for
10 min at 4 °C, equal amounts of total protein (15 μg/lane) were
separated by SDS-PAGE under reducing conditions and
transferred onto a 0.2-mm nitrocellulose membrane (BioRad)
using a Trans-Blot SemiDry transfer device (BioRad). Mem-
branes were blocked for 1 h at room temperature or overnight at
4 °C with Odyssey Blocking Reagent (LI-COR). For immuno-
detection, the membranes were incubated at 37 °C with the
respective primary and secondary antibodies for 30 min each in
Odyssey Blocking Reagent. Between each incubation step,
membranes were washed with PBS supplemented with 0.1%
Tween 20. After two final wash steps in absence of detergent,the signal was acquired using the Odyssey Infrared Imaging
System (LI-COR).
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